2024 Q3 Form 10-Q Financial Statement

#000137647424000448 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $275.5K $186.9K
YoY Change 47.83% -31.85%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $134.0K
YoY Change -49.4%
% of Gross Profit
Research & Development $97.80K $93.87K
YoY Change -7.34% -48.27%
% of Gross Profit
Depreciation & Amortization $10.04K
YoY Change -0.1%
% of Gross Profit
Operating Expenses $142.3K $144.1K
YoY Change -24.05% -47.59%
Operating Profit $133.1K $42.86K
YoY Change -12767.17% -7255.43%
Interest Expense $45.97K $46.47K
YoY Change 21.91% 27.38%
% of Operating Profit 34.53% 108.43%
Other Income/Expense, Net
YoY Change
Pretax Income -$3.610K
YoY Change -90.26%
Income Tax
% Of Pretax Income
Net Earnings $87.17K -$3.612K
YoY Change -324.91% -90.26%
Net Earnings / Revenue 31.64% -1.93%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 554.2M shares 554.2M shares
Diluted Shares Outstanding 613.2M shares 613.2M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.220K
YoY Change -19.57%
Cash & Equivalents $2.336K $2.218K
Short-Term Investments
Other Short-Term Assets $1.520K
YoY Change 0.0%
Inventory
Prepaid Expenses $1.519K $1.519K
Receivables $141.2K $63.29K
Other Receivables $0.00
Total Short-Term Assets $145.1K $67.03K
YoY Change 72.78% 0.75%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $0.00
YoY Change
Goodwill $2.185M $2.185M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $661.9K
YoY Change 0.0%
Other Assets $494.0K $504.0K
YoY Change -7.52% -7.38%
Total Long-Term Assets $3.620M $3.632M
YoY Change -0.29% -0.24%
TOTAL ASSETS
Total Short-Term Assets $145.1K $67.03K
Total Long-Term Assets $3.620M $3.632M
Total Assets $3.765M $3.699M
YoY Change 1.36% -0.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $692.3K $587.5K
YoY Change -40.64% -46.31%
Accrued Expenses $575.2K $555.4K
YoY Change 180.2% 14.24%
Deferred Revenue
YoY Change
Short-Term Debt $21.00K $21.00K
YoY Change 0.0% 0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.849M $1.498M
YoY Change -3.18% -19.02%
LONG-TERM LIABILITIES
Long-Term Debt $1.974M
YoY Change 23.16%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.974M
YoY Change 23.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.849M $1.498M
Total Long-Term Liabilities $1.974M
Total Liabilities $3.451M $3.472M
YoY Change -1.37% 0.56%
SHAREHOLDERS EQUITY
Retained Earnings -$2.276M -$2.363M
YoY Change -5.28% -0.04%
Common Stock $613.2K $613.2K
YoY Change 19.25% 19.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$314.2K $227.0K
YoY Change
Total Liabilities & Shareholders Equity $3.765M $3.699M
YoY Change 1.36% -0.22%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $87.17K -$3.612K
YoY Change -324.91% -90.26%
Depreciation, Depletion And Amortization $10.04K
YoY Change -0.1%
Cash From Operating Activities -$30.36K
YoY Change -141.97%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 30.33K
YoY Change -143.24%
NET CHANGE
Cash From Operating Activities -30.36K
Cash From Investing Activities 0.000
Cash From Financing Activities 30.33K
Net Change In Cash -30.00
YoY Change -101.37%
FREE CASH FLOW
Cash From Operating Activities -$30.36K
Capital Expenditures $0.00
Free Cash Flow -$30.36K
YoY Change -141.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54739
dei Entity Registrant Name
EntityRegistrantName
Ameritek Ventures, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-2380777
dei Entity Address Address Line1
EntityAddressAddressLine1
325 N Milwaukee Ave. Suite G1
dei Entity Address City Or Town
EntityAddressCityOrTown
Wheeling
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60090
dei Entity Address Address Description
EntityAddressAddressDescription
Address of principal executive offices
dei City Area Code
CityAreaCode
312
dei Local Phone Number
LocalPhoneNumber
239-3574
dei Phone Fax Number Description
PhoneFaxNumberDescription
Issuer’s telephone number
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
554226791 shares
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.001
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2218 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5618 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
63294 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
132380 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1519 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1519 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
67031 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
139517 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2024Q2 us-gaap Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums
UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums
31416 usd
CY2023Q4 us-gaap Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums
UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums
35112 usd
CY2024Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
661886 usd
CY2023Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
661886 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
250000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
250000 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
504027 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
524117 usd
CY2024Q2 us-gaap Goodwill
Goodwill
2184715 usd
CY2023Q4 us-gaap Goodwill
Goodwill
2184715 usd
CY2024Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
3632044 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
3655830 usd
CY2024Q2 us-gaap Assets
Assets
3699075 usd
CY2023Q4 us-gaap Assets
Assets
3795347 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
587505 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
987071 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
555447 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
547204 usd
CY2024Q2 us-gaap Deferred Revenue
DeferredRevenue
334464 usd
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
151005 usd
CY2024Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
21000 usd
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
21000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1498416 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1706280 usd
CY2024Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
1973676 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1933448 usd
CY2024Q2 us-gaap Liabilities
Liabilities
3472092 usd
CY2023Q4 us-gaap Liabilities
Liabilities
3639728 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
583226791 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
583226791 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
554226791 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
554226791 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
613227 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
554227 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
881317 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
885038 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2363174 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2379259 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
226983 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
155619 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3699075 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3795347 usd
CY2024Q2 us-gaap Revenues
Revenues
186920 usd
CY2023Q2 us-gaap Revenues
Revenues
274279 usd
us-gaap Revenues
Revenues
402842 usd
us-gaap Revenues
Revenues
516599 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
93868 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
181447 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
196637 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
301092 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
40146 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
83385 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
80898 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
121788 usd
CY2024Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10045 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10046 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
20090 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
62549 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
144059 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
274878 usd
us-gaap Operating Expenses
OperatingExpenses
297625 usd
us-gaap Operating Expenses
OperatingExpenses
485429 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
42861 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-599 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
105217 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
31170 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
46473 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
36484 usd
us-gaap Interest Expense
InterestExpense
89132 usd
us-gaap Interest Expense
InterestExpense
75010 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-3612 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-37083 usd
us-gaap Net Income Loss
NetIncomeLoss
16085 usd
us-gaap Net Income Loss
NetIncomeLoss
-43840 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
613226791 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
514226791 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
613226791 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
514226791 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
613226791 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
514226791 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
613226791 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
514226791 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
298369 usd
us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-43840 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
254529 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
155619 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
55280 usd
us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
16085 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
226984 usd
us-gaap Profit Loss
ProfitLoss
16085 usd
us-gaap Profit Loss
ProfitLoss
-43840 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20090 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
62549 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
3696 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-69086 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-311750 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-399566 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-96759 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
60009 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
59367 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
183459 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-137681 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-47141 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
155386 usd
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
0 usd
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
41300 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
0 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
26367 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 usd
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
23926 usd
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
153379 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
43741 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-153379 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3400 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2007 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5618 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
751 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2218 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2758 usd
us-gaap Interest Paid
InterestPaid
25428 usd
us-gaap Interest Paid
InterestPaid
7327 usd
us-gaap Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
59000 usd
us-gaap Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
0 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font:9pt Times New Roman;margin-top:0pt;margin-bottom:10pt;margin-left:18pt"><kbd style="position:absolute;font:9pt Times New Roman;margin-left:-18pt"><b>1.</b></kbd><b>GENERAL ORGANIZATION AND BUSINESS</b> </p> <p style="font:9pt Times New Roman;margin:0;text-align:justify">The Company was organized on December 27, 2010, under the laws of the State of Nevada, as ATVROCKN. On June 20, 2017, the Company changed its corporate name to Ameritek Ventures, Inc (“Ameritek Ventures” or “Ameritek” or the “Company”).</p> <p style="font:9pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:9pt Times New Roman;margin:0;text-align:justify">Ameritek is a group of companies that provides various world-class software and hardware products and services beneficial to businesses, organizations, and governments. We have an established presence in the warehouse solutions market. With Interactive Systems, Inc. we provide software inventory management and with interlinkONE, Inc. we provide SaaS cloud-based solutions for warehouse and inventory fulfillment. We manufacture and innovate advanced technological developments in the medical industry, such as the DittoMask high-filtration mask. We also develop blockchain technology software programs under WebBeeO and CordTell companies. Furthermore, Ameritek Ventures explores augmented reality technology with Augmum, Inc. Meanwhile, our vertical landing aircraft service from AeroPass, Inc. takes ZenaDrone technology to a higher level with members-only passenger first-class transport across cities. Ecker Capital, LLC is our merger and acquisition division. ESM Software, Inc. is a software technology provider specializing in developing business strategy management solutions. The Company also recently created a new business, Equock, Inc., with which Ameritek will develop an electric bicycle with a focus on the growing online delivery industry.</p>
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2010-12-27
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
us-gaap Use Of Estimates
UseOfEstimates
<p style="font:9pt Times New Roman;margin:0;text-align:justify"><b>Use of Estimates</b></p> <p style="font:9pt Times New Roman;margin:0;text-align:justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2024Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
7694 usd
CY2023Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
7694 usd
CY2024Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
28568 usd
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
28568 usd
CY2024Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4200 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4200 usd
CY2024Q2 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
2783 usd
CY2023Q4 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
2783 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
43245 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
43245 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
43245 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
43245 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2023Q4 fil Product Development Costs
ProductDevelopmentCosts
602722 usd
fil Product Development Addition
ProductDevelopmentAddition
0 usd
CY2024Q2 fil Product Development Costs
ProductDevelopmentCosts
602722 usd
CY2023Q4 fil Product Development Total Amortizatiion
ProductDevelopmentTotalAmortizatiion
78605 usd
fil Product Development Amortization
ProductDevelopmentAmortization
10045 usd
CY2024Q2 fil Product Development Total Amortizatiion
ProductDevelopmentTotalAmortizatiion
20091 usd
CY2024Q2 fil Product Development Net Book Value
ProductDevelopmentNetBookValue
502027 usd
CY2023Q4 fil Goodwill Total Cost
GoodwillTotalCost
3150159 usd
fil Transfer To Goodwill
TransferToGoodwill
2184715 usd
CY2024Q2 fil Goodwill Total Cost
GoodwillTotalCost
965444 usd
CY2023Q4 fil Goodwill Book Value
GoodwillBookValue
2791472 usd
CY2023Q4 fil Goodwill Amortization
GoodwillAmortization
358687 usd
fil Transfer To Goodwill Book Value
TransferToGoodwillBookValue
2184716 usd
fil Goodwill Book Value Amortization
GoodwillBookValueAmortization
82637 usd
CY2024Q2 fil Goodwill Amortization
GoodwillAmortization
441324 usd
CY2024Q2 fil Goodwill Book Value
GoodwillBookValue
524119 usd
us-gaap Debt Instrument Issuer
DebtInstrumentIssuer
Ameritek
CY2024Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
185000 usd
us-gaap Debt Instrument Description
DebtInstrumentDescription
non-convertible promissory note
us-gaap Debt Instrument Issuance Date1
DebtInstrumentIssuanceDate1
2021-05-13
CY2024Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.15 pure
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
24966 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
4341 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
24596 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
3596 usd
CY2024Q2 fil Promissory Notes Current
PromissoryNotesCurrent
0 usd
CY2023Q4 fil Promissory Notes Current
PromissoryNotesCurrent
0 usd
CY2024Q2 fil Promissory Notes Non Current
PromissoryNotesNonCurrent
1973676 usd
CY2023Q4 fil Promissory Notes Non Current
PromissoryNotesNonCurrent
1933448 usd
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
583226791 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
554226791 shares
CY2023Q2 fil Accounts Payable Balance
AccountsPayableBalance
1158694 usd
CY2023Q2 fil Accounts Payable Balance Net
AccountsPayableBalanceNet
816314 usd
us-gaap Loss Contingency Actions Taken By Plaintiff
LossContingencyActionsTakenByPlaintiff
Meridian Pacific Holdings, LLC filed a lawsuit against certain directors, officers, affiliates, and the Company for breach of contract and fraud
us-gaap Loss Contingency Name Of Plaintiff
LossContingencyNameOfPlaintiff
Meridian Pacific Holdings, LLC
us-gaap Loss Contingency Allegations
LossContingencyAllegations
breach of contract and fraud
us-gaap Gain Contingency Description
GainContingencyDescription
The Company filed a lawsuit in the Clark County, Nevada, court against Clinton L. Stokes, III, the former owner of the Company, to settle the matter of shares ownership
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
0 usd

Files In Submission

Name View Source Status
0001376474-24-000448-index-headers.html Edgar Link pending
0001376474-24-000448-index.html Edgar Link pending
0001376474-24-000448.txt Edgar Link pending
0001376474-24-000448-xbrl.zip Edgar Link pending
atvk-20240630.htm Edgar Link pending
atvk-20240630.xsd Edgar Link pending
av_ex31z1.htm Edgar Link pending
av_ex31z2.htm Edgar Link pending
av_ex32z1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
atvk-20240630_def.xml Edgar Link unprocessable
atvk-20240630_lab.xml Edgar Link unprocessable
atvk-20240630_htm.xml Edgar Link completed
atvk-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
atvk-20240630_cal.xml Edgar Link unprocessable